Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This entry represents a heterogeneous collection of distinct molecular targets and signaling pathways rather than a single therapeutic entity. It encompasses key regulators of cellular homeostasis, including Nuclear factor erythroid 2-related factor 2 (Nrf2) for antioxidant defense (UniProt Q16236) and Nuclear factor kappa B (NF-κB) for inflammatory responses (PMID: 31040565). Peroxisome proliferator-activated receptor gamma (PPARγ) is also included, serving as a critical nuclear receptor for metabolic regulation and lipid storage (UniProt P37231). Furthermore, the group covers the insulin signaling cascade and various proteins involved in managing oxidative stress, such as superoxide dismutase and glutathione peroxidase (PMID: 21864752). These pathways are intricately linked; for instance, Nrf2 and NF-κB exhibit significant cross-talk to balance inflammation and cytoprotection (PMID: 28236333). Dysregulation across these systems is a hallmark of chronic conditions, including type 2 diabetes, cardiovascular disease, and neurodegeneration. Pharmacological intervention involves diverse strategies, such as using thiazolidinediones to activate PPARγ or dimethyl fumarate to trigger the Nrf2 pathway. Because this entry combines multiple unrelated or broadly related pathways, it does not constitute a single valid pharmacological target for structured drug discovery.
This entry describes a heterogeneous group of targets with distinct mechanisms: Nrf2 activators induce antioxidant response elements (ARE); NF-κB inhibitors block pro-inflammatory gene transcription; PPARγ agonists activate nuclear receptors to improve lipid and glucose metabolism; and insulin signaling components facilitate glucose uptake via GLUT4 translocation.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nuclear factor erythroid 2-related factor 2, Nuclear factor kappa B, Peroxisome proliferator-activated receptor gamma, Insulin signaling pathway, and Oxidative stress proteins.